 |
111 Diseases |  |
73 Trials |
|
73 Trials |  |
1509 News |  |
| «12...25262728293031323334353637» |
- memantine / Generic mfg.
Trial withdrawal, Monotherapy: Memantine Monotherapy for Executive Dysfunction and ADHD (clinicaltrials.gov) - Sep 22, 2013
P=N/A, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Withdrawn
- memantine / Generic mfg.
Enrollment change, Monotherapy: Memantine Monotherapy for Executive Dysfunction and ADHD (clinicaltrials.gov) - Sep 22, 2013
P=N/A, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Withdrawn N=40 --> 0
- | memantine / Generic mfg.
Enrollment change: MM: Series Studies of Bipolar Disorder-Valproate add-on Memantine (clinicaltrials.gov) - Sep 15, 2013
P2/3, N=219, Completed, Sponsor: National Cheng-Kung University Hospital
N=40 --> 0 N=320 --> 219
- | memantine / Generic mfg.
Trial completion: MM: Series Studies of Bipolar Disorder-Valproate add-on Memantine (clinicaltrials.gov) - Sep 15, 2013
P2/3, N=219, Completed, Sponsor: National Cheng-Kung University Hospital
N=320 --> 219 Recruiting --> Completed
- | memantine / Generic mfg.
Enrollment closed: Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults (clinicaltrials.gov) - Sep 8, 2013
P3, N=90, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Recruiting --> Active, not recruiting
- memantine / Generic mfg.
Enrollment closed: Treatment Resistant Geriatric Depression in Primary Care (clinicaltrials.gov) - Aug 27, 2013
P4, N=12, Active, not recruiting, Sponsor: Mclean Hospital
Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- | galantamine hydrobromide / Generic mfg., memantine / Generic mfg.
New P4 trial: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease (clinicaltrials.gov) - Aug 12, 2013
P4, N=232, Completed, Sponsor: Charite University, Berlin, Germany
- galantamine hydrobromide / Generic mfg., memantine / Generic mfg.
Trial completion: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease (clinicaltrials.gov) - Aug 11, 2013
P4, N=232, Completed, Sponsor: Charite University, Berlin, Germany
Completed --> Active, not recruiting Not yet recruiting --> Completed
- || memantine / Generic mfg., escitalopram / Generic mfg.
New P3 trial: Brain Aging and Treatment Response in Geriatric Depression (clinicaltrials.gov) - Jul 15, 2013
P3, N=134, Recruiting, Sponsor: University of California, Los Angeles
- || memantine / Generic mfg., escitalopram / Generic mfg.
New P2/3 trial: Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment (clinicaltrials.gov) - Jun 11, 2013
P2/3, N=60, Completed, Sponsor: New York State Psychiatric Institute
- |||||||||| Kinaction (masitinib) / AB Science
New P3 trial, P3 data: Masitinib in Patients With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Jun 5, 2013
P3, N=396, Recruiting, Sponsor: AB Science
- | memantine / Generic mfg.
New P4 trial: ROMEO-AD: Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease (clinicaltrials.gov) - May 6, 2013
P4, N=188, Recruiting, Sponsor: Konkuk University Medical Center
- riluzole / Generic mfg., memantine / Generic mfg.
Trial termination: Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes (clinicaltrials.gov) - Apr 18, 2013
P4, N=20, Terminated, Sponsor: University of Texas Southwestern Medical Center
Not yet recruiting --> Completed Recruiting --> Terminated; Study finished enrollment but data was never sent for publishing.
- riluzole / Generic mfg., memantine / Generic mfg.
Enrollment change: Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes (clinicaltrials.gov) - Apr 18, 2013
P4, N=20, Terminated, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Terminated; Study finished enrollment but data was never sent for publishing. N=25 --> 20
- LMTX (hydromethylthionine) / TauRx
Trial termination: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
N=25 --> 20 Recruiting --> Terminated; This study has been terminated for administrative reasons only.
- LMTX (hydromethylthionine) / TauRx
Enrollment change: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Terminated; This study has been terminated for administrative reasons only. N=60 --> 9
- | memantine / Generic mfg.
Trial completion: MM opioid: Psychopharmacotherapy in Multiple Substances Abuse (clinicaltrials.gov) - Feb 26, 2013
P3, N=200, Completed, Sponsor: National Cheng-Kung University Hospital
N=60 --> 9 Recruiting --> Completed
- naltrexone / Generic mfg., memantine / Generic mfg.
Trial initiation date: NAMHS-1: Memantine and Naltrexone Treatment for Opioid Dependence (clinicaltrials.gov) - Jan 27, 2013
P2, N=81, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed Initiation date: Jul 1999 --> Jun 2005
- | memantine / Generic mfg.
Trial initiation date: NAMHS: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (clinicaltrials.gov) - Dec 12, 2012
P2/3, N=82, Completed, Sponsor: New York State Psychiatric Institute
Initiation date: Jul 1999 --> Jun 2005 Initiation date: Jun 2005 --> Jun 2008
- | memantine / Generic mfg.
Enrollment change: NAMHS: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (clinicaltrials.gov) - Dec 12, 2012
P2/3, N=82, Completed, Sponsor: New York State Psychiatric Institute
Initiation date: Jun 2005 --> Jun 2008 N=200 --> 82
- New P2 trial: Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis (clinicaltrials.gov) - Dec 4, 2012
P2, N=10, Completed, Sponsor: Hospices Civils de Lyon
- ketamine / Generic mfg.
Enrollment open: Study of NMDA Antagonists and Neuropathic Pain (clinicaltrials.gov) - Oct 7, 2012
P2, N=60, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
N=200 --> 82 Not yet recruiting --> Recruiting
- memantine / Generic mfg.
Enrollment open: Prophylaxis of Neuropathic Pain by m (clinicaltrials.gov) - Oct 7, 2012
P3, N=40, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||| sembragiline (RO4602522) / Roche, Evotec
Enrollment open: MAyflOwer RoAD: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy (clinicaltrials.gov) - Sep 13, 2012
P2, N=495, Recruiting, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| sembragiline (RO4602522) / Roche, Evotec
New P2 trial: MAyflOwer RoAD: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy (clinicaltrials.gov) - Aug 30, 2012
P2, N=495, Recruiting, Sponsor: Hoffmann-La Roche
- | memantine / Generic mfg.
Trial completion: Study on Cognitive Disorders of Multiple Sclerosis (clinicaltrials.gov) - Aug 30, 2012
P3, N=90, Completed, Sponsor: University Hospital, Caen
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | memantine / Generic mfg.
Enrollment change: Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults (clinicaltrials.gov) - Aug 13, 2012
P3, N=90, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Completed N=60 --> 90
- memantine / Generic mfg.
New P4 trial: Attenuation of Corticosteroid Induced Hippocampal Changes (clinicaltrials.gov) - Jul 31, 2012
P4, N=50, Recruiting, Sponsor: University of Texas Southwestern Medical Center
- || memantine / Generic mfg.
New P3 trial: Randomised Controlled Trial of Memantine in Fibromyalgia (clinicaltrials.gov) - Jul 29, 2012
P3, N=60, Not yet recruiting, Sponsor: Aragon Institute of Health Sciences
- memantine / Generic mfg.
Trial initiation date: Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking (clinicaltrials.gov) - Jul 23, 2012
P2, N=130, Active, not recruiting, Sponsor: Wake Forest Cancer Center CCOP Research Base
N=60 --> 90 Initiation date: Feb 2012 --> Aug 2012
- memantine / Generic mfg.
Trial completion: Family History Study of Alcohol Consumption Using Memantine (clinicaltrials.gov) - Jul 1, 2012
P2, N=111, Completed, Sponsor: Yale University
Initiation date: Feb 2012 --> Aug 2012 Recruiting --> Completed
- memantine / Generic mfg.
Trial completion: Memantine in the Treatment of Kleptomania (clinicaltrials.gov) - Jun 26, 2012
P2, N=10, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Completed Recruiting --> Completed
- LMTX (hydromethylthionine) / TauRx
New P2 trial: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Jun 20, 2012
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
- memantine / Generic mfg.
Trial termination: Memantine-MS: Memantine Therapy for Multiple Sclerosis (clinicaltrials.gov) - Jun 6, 2012
P2, N=20, Terminated, Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Recruiting --> Completed Suspended --> Terminated; Unexpected side-effects: reversible and mild to moderate neurological impairment
- || memantine / Generic mfg.
Trial completion, FDG PET: Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia (clinicaltrials.gov) - May 31, 2012
P3, N=17, Completed, Sponsor: Tiffany Chow, MD
Suspended --> Terminated; Unexpected side-effects: reversible and mild to moderate neurological impairment Active, not recruiting --> Completed
- memantine / Generic mfg.
Enrollment change: Treatment Resistant Geriatric Depression in Primary Care (clinicaltrials.gov) - May 20, 2012
P4, N=12, Active, not recruiting, Sponsor: Mclean Hospital
Active, not recruiting --> Completed N=40 --> 12
- | ketamine / Generic mfg.
New P2 trial: Study of NMDA Antagonists and Neuropathic Pain (clinicaltrials.gov) - May 16, 2012
P2, N=60, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- memantine / Generic mfg.
Trial initiation date: Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=33, Completed, Sponsor: Massachusetts General Hospital
N=40 --> 12 Initiation date: Feb 2012 --> May 2012
- memantine / Generic mfg.
Enrollment change: Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression (clinicaltrials.gov) - Mar 25, 2012
P4, N=29, Completed, Sponsor: Indiana University School of Medicine
Initiation date: Feb 2012 --> May 2012 N=40 --> 29
- memantine / Generic mfg.
Trial completion: Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression (clinicaltrials.gov) - Mar 25, 2012
P4, N=29, Completed, Sponsor: Indiana University School of Medicine
N=40 --> 29 Active, not recruiting --> Completed
- memantine / Generic mfg.
Trial completion: Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults (clinicaltrials.gov) - Mar 22, 2012
P4, N=35, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | memantine / Generic mfg.
Biomarker, New P1/2 trial: Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia (clinicaltrials.gov) - Mar 12, 2012
P1/2, N=60, Recruiting, Sponsor: University of California, San Diego
- memantine / Generic mfg.
New P3 trial: Prophylaxis of Neuropathic Pain by m (clinicaltrials.gov) - Feb 20, 2012
P3, N=40, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- | memantine / Generic mfg.
New P2 trial: Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking (clinicaltrials.gov) - Feb 15, 2012
P2, N=130, Active, not recruiting, Sponsor: Wake Forest Cancer Center CCOP Research Base
- memantine / Generic mfg.
Trial initiation date: A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM) (clinicaltrials.gov) - Jan 31, 2012
P2, N=60, Recruiting, Sponsor: Evdokia Anagnostou
Active, not recruiting --> Completed Initiation date: Jun 2011 --> Dec 2011
- memantine / Generic mfg.
Enrollment open: A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM) (clinicaltrials.gov) - Jan 31, 2012
P2, N=60, Recruiting, Sponsor: Evdokia Anagnostou
Initiation date: Jun 2011 --> Dec 2011 Not yet recruiting --> Recruiting
- | naltrexone / Generic mfg., memantine / Generic mfg.
New P2 trial: Naltrexone and Memantine Effects on Alcohol Drinking Behaviors (clinicaltrials.gov) - Jan 24, 2012
P2, N=86, Recruiting, Sponsor: Yale University
- | memantine / Generic mfg.
Trial termination: Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease (clinicaltrials.gov) - Jan 17, 2012
P3, N=369, Terminated, Sponsor: H. Lundbeck A/S
Not yet recruiting --> Recruiting Completed --> Terminated
- modafinil / Generic mfg., memantine / Generic mfg.
Enrollment open: Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers (clinicaltrials.gov) - Dec 4, 2011
P1, N=36, Recruiting, Sponsor: Qualissima
Completed --> Terminated Not yet recruiting --> Recruiting
- memantine / Generic mfg.
New P2 trial: Study of the efficacy of the drug memantine in the treatment of fibromialgia Estudio que evalua la eficacia del medicamento memantina en el tratamiento de la fibromialgia (EUDRACT) - Nov 2, 2011
P2, N=10, Ongoing, Sponsor: Javier García Campayo